Cubist Systematic Strategies’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Cubist Systematic Strategies’s Portfolio MBII Stock Details MBII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-9,288	Closed	-$11K	–	5050
2022 Q2	$11K	Buy	+9,288	New	+$9.71K	﹤0.01%	4266
2021 Q4	–	Sell	-20,550	Closed	-$19K	–	3738
2021 Q3	$19K	Sell	20,550 -15,548	-43%	-$18.7K	﹤0.01%	2890
2021 Q2	$60K	Sell	36,098 -19,011	-34%	-$31.8K	﹤0.01%	2773
2021 Q1	$115K	Buy	+55,109	New	+$114K	﹤0.01%	2616

Cubist Systematic Strategies's MBII Position: Q3 2022 in Review

Cubist Systematic Strategies sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 9,288 shares — an estimated $11K sold.

Cubist Systematic Strategies first reported a position in MBII in Q1 2021 and held it in 4 quarters. The position peaked at $115K in Q1 2021. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.

Cubist Systematic Strategies reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
Cubist Systematic Strategies sold 9,288 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $11K.
Cubist Systematic Strategies first reported a position in Marrone Bio Innovations, Inc. in Q1 2021 and held it in 4 quarters.
Cubist Systematic Strategies's Marrone Bio Innovations, Inc. position peaked at $115K in Q1 2021.
0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.

Based on Cubist Systematic Strategies's 13F filing for Q3 2022, filed 14 Nov 2022.